Xiao Hang Tong
Vorsitzender bei Shanghai Cardimed Medical Technology Co. Ltd.
Profil
Xiao Hang Tong currently works at Shanghai Cardimed Medical Technology Co. Ltd., as Chairman from 2015, AnHeart Therapeutics (Hangzhou) Co., Ltd., as Chairman, Insight Lifetech Co., Ltd., as Non-Executive Director from 2017, and Lingke Pharmaceutical Hangzhou Co., Ltd., as Director from 2020.
Dr. Tong also formerly worked at Suzhou Decheng Life Science Venture Capital (Shanghai), as Vice President-Investment from 2014 to 2020.
Dr. Tong received his undergraduate degree in 2010 from Peking University, undergraduate degree in 2005 from the University of Science & Technology of China, and doctorate degree in 2010 from Chinese Academy of Sciences.
Aktive Positionen von Xiao Hang Tong
| Unternehmen | Position | Beginn |
|---|---|---|
Insight Lifetech Co., Ltd.
 Insight Lifetech Co., Ltd. Medical SpecialtiesHealth Technology Insight Lifetech Co., Ltd. engages in the manufacture and sale of interventional cardiovascular diagnostic and therapy products. It offers exchange fractional flow reserve (FFR) microcatheters, cardiovascular pressure measurement (CPM) systems, intravascular ultrasound systems, and microcatheters for complex percutaneous coronary intervention (PCI). The company was founded by Xiao Yang Fu and Li Li Chen on December 11, 2015 and is headquartered in Shenzhen, China. | Direktor/Vorstandsmitglied | 21.06.2017 |
Shanghai Cardimed Medical Technology Co. Ltd.
 Shanghai Cardimed Medical Technology Co. Ltd. Medical DistributorsDistribution Services Shanghai Cardimed Medical Technology Co. Ltd. is a company that distributes hemodialysis and renal care equipment. The company was founded in 2015 and is based in Shanghai, China. | Vorsitzender | 01.10.2015 |
| Lingke Pharmaceutical Hangzhou Co., Ltd. | Direktor/Vorstandsmitglied | 01.02.2020 |
AnHeart Therapeutics (Hangzhou) Co., Ltd.
 AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | Vorsitzender | - |
Ehemalige bekannte Positionen von Xiao Hang Tong
| Unternehmen | Position | Ende |
|---|---|---|
| Suzhou Decheng Life Science Venture Capital (Shanghai) | Chief Investment Officer | 01.05.2020 |
Ausbildung von Xiao Hang Tong
| University of Science & Technology of China | Undergraduate Degree |
| Peking University | Undergraduate Degree |
| Chinese Academy of Sciences | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Insight Lifetech Co., Ltd.
Insight Lifetech Co., Ltd. Medical SpecialtiesHealth Technology Insight Lifetech Co., Ltd. engages in the manufacture and sale of interventional cardiovascular diagnostic and therapy products. It offers exchange fractional flow reserve (FFR) microcatheters, cardiovascular pressure measurement (CPM) systems, intravascular ultrasound systems, and microcatheters for complex percutaneous coronary intervention (PCI). The company was founded by Xiao Yang Fu and Li Li Chen on December 11, 2015 and is headquartered in Shenzhen, China. | Health Technology |
Shanghai Cardimed Medical Technology Co. Ltd.
Shanghai Cardimed Medical Technology Co. Ltd. Medical DistributorsDistribution Services Shanghai Cardimed Medical Technology Co. Ltd. is a company that distributes hemodialysis and renal care equipment. The company was founded in 2015 and is based in Shanghai, China. | Distribution Services |
| Lingke Pharmaceutical Hangzhou Co., Ltd. | |
| Suzhou Decheng Life Science Venture Capital (Shanghai) | |
AnHeart Therapeutics (Hangzhou) Co., Ltd.
AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | Commercial Services |
